Optimising child-friendly TB preventive treatment regimens
Interest-holders favoured 3HP for its lower dosing burden, despite concerns about pill burden. Child-friendly, fixed-dose formulations and consideration of caregiver and child preferences are essential to improving adherence and treatment outcomes.
Authors
- Alanna Bergman (ORCID: https://orcid.org/0000-0003-1474-7765)
- Ahmed Bedru
- Gavin Churchyard (ORCID: https://orcid.org/0000-0002-4269-3699)
- Nicole Salazar‐Austin (ORCID: https://orcid.org/0000-0002-9875-9319)
- Richard E. Chaisson (ORCID: https://orcid.org/0000-0003-4710-925X)
- Deanna Kerrigan (ORCID: https://orcid.org/0000-0001-7401-9159)
- Fiseha Mulatu
- Christiaan Mulder (ORCID: https://orcid.org/0000-0003-2628-7460)
Institutions
- Johns Hopkins University (US)
- George Washington University (US)
- TuBerculosis Vaccine Initiative (NL)
- Johns Hopkins Medicine (US)
- Government of Ethiopia (ET)
- Ethiopian Civil Service University (ET)
- Aurum Institute (ZA)
- Amsterdam Institute for Global Health and Development (NL)
- University of Virginia (US)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2025-11-01
- DOI
- https://doi.org/10.5588/ijtldopen.25.0369
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00